Beam Therapeutics Inc. Common Stock (BEAM) Sentiment

30-day SentiSense Score 0.58 · Neutral · ▼ cooling · as of 2026-08-09

BEAM sentiment is neutral (30-day SentiSense Score 1) and cooling from a month ago; there is no reading for today yet. Attention averages ~5 mentions/day (1 today).

Sentiment (30-day)
Neutral
SentiSense Score (30-day avg)
0.58
Mentions / day (30-day avg)
5 (1 today)

Where the conversation is happening

News
Neutral · 51% of mentions
X
Bullish · 25% of mentions
Reddit
Neutral · 13% of mentions
YouTube
Neutral · 11% of mentions

Related tickers

CRSP, ARWR

What's driving it

  • Prime Medicine Wins Arbitration Over AATD Therapy PM647 (+0.6)
  • FDA Clears Gene Therapy Trial for Phenylketonuria (PKU) (+0.78)
  • Beam Therapeutics Advances Phase 1/2 Trial for AAT Deficiency with Gene-Editing Therapy (+1)

Live SentiSense Score, sentiment history, and per-source breakdown for Beam Therapeutics Inc. Common Stock on SentiSense.

See how BEAM's sector compares in the market sentiment heatmap